Martin A Vidal1, Gail E Kilroy, Jill R Johnson, Mandi J Lopez, Rustin M Moore, Jeffrey M Gimble. 1. Equine Health Studies Program, Department of Veterinary Clinical Sciences, School of Veterinary Medicine and the Stem Cell Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. mvidal@vetmed.lsu.edu
Abstract
OBJECTIVES: To characterize equine bone marrow (BM)-derived mesenchymal stem cell (MSC) growth characteristics and frequency as well as their adipogenic and osteogenic differentiation potential. STUDY DESIGN: In vitro experimental study. ANIMALS: Foals (n=3, age range, 17-51 days) and young horses (n=5, age range, 9 months to 5 years). METHODS: Equine MSCs were harvested and isolated from sternal BM aspirates and grown up to passage 10 to determine cell-doubling (CD) characteristics. Limit dilution assays were performed on primary and passaged MSCs to determine the frequency of colony-forming units with a fibroblastic phenotype (CFU-F), and the frequency of MSC differentiation into adipocytes (CFU-Ad) and osteoblasts (CFU-Ob). RESULTS: Initial MSC isolates had a lag phase with a significantly longer CD time (DT=4.9+/-1.6 days) compared with the average DT (1.4+/-0.22 days) of subsequent MSC passages. Approximately 1 in 4224+/-3265 of the total nucleated BM cells displayed fibroblast colony-forming activity. Primary MSCs differentiated in response to adipogenic and osteogenic inductive conditions and maintained their differentiation potential during subsequent passages. CONCLUSIONS: The frequency, in vitro growth rate, and adipogenic and osteogenic differentiation potential of foals and young adult horses are similar to those documented for BM MSCs of other mammalian species. CLINICAL RELEVANCE: The results have direct relevance to the use of BM as a potential source of adult stem cells for tissue engineering applications in equine veterinary medicine.
OBJECTIVES: To characterize equine bone marrow (BM)-derived mesenchymal stem cell (MSC) growth characteristics and frequency as well as their adipogenic and osteogenic differentiation potential. STUDY DESIGN: In vitro experimental study. ANIMALS: Foals (n=3, age range, 17-51 days) and young horses (n=5, age range, 9 months to 5 years). METHODS:Equine MSCs were harvested and isolated from sternal BM aspirates and grown up to passage 10 to determine cell-doubling (CD) characteristics. Limit dilution assays were performed on primary and passaged MSCs to determine the frequency of colony-forming units with a fibroblastic phenotype (CFU-F), and the frequency of MSC differentiation into adipocytes (CFU-Ad) and osteoblasts (CFU-Ob). RESULTS: Initial MSC isolates had a lag phase with a significantly longer CD time (DT=4.9+/-1.6 days) compared with the average DT (1.4+/-0.22 days) of subsequent MSC passages. Approximately 1 in 4224+/-3265 of the total nucleated BM cells displayed fibroblast colony-forming activity. Primary MSCs differentiated in response to adipogenic and osteogenic inductive conditions and maintained their differentiation potential during subsequent passages. CONCLUSIONS: The frequency, in vitro growth rate, and adipogenic and osteogenic differentiation potential of foals and young adult horses are similar to those documented for BM MSCs of other mammalian species. CLINICAL RELEVANCE: The results have direct relevance to the use of BM as a potential source of adult stem cells for tissue engineering applications in equine veterinary medicine.
Authors: Jaroslaw Staszkiewicz; Trivia P Frazier; Brian G Rowan; Bruce A Bunnell; Ernest S Chiu; Jeffrey M Gimble; Barbara Gawronska-Kozak Journal: Stem Cells Dev Date: 2010-01 Impact factor: 3.272
Authors: Nan K Huff; Nakia D Spencer; Jeffrey M Gimble; Gregory J Bagby; Steve Nelson; Mandi J Lopez Journal: Alcohol Date: 2011-03-04 Impact factor: 2.405
Authors: Boaz Arzi; Amir Kol; Brian Murphy; Naomi J Walker; Joshua A Wood; Kaitlin Clark; Frank J M Verstraete; Dori L Borjesson Journal: Stem Cells Dev Date: 2014-12-31 Impact factor: 3.272
Authors: Deanne J Whitworth; Dmitry A Ovchinnikov; Jane Sun; Patrick R J Fortuna; Ernst J Wolvetang Journal: Stem Cells Dev Date: 2014-04-01 Impact factor: 3.272
Authors: A M M T Reza; S Shiwani; N K Singh; J D Lohakare; S J Lee; D K Jeong; J Y Han; D Rengaraj; B W Lee Journal: In Vitro Cell Dev Biol Anim Date: 2013-10-08 Impact factor: 2.416
Authors: Martin A Vidal; Sandra O Robinson; Mandi J Lopez; Daniel B Paulsen; Olga Borkhsenious; Jill R Johnson; Rustin M Moore; Jeffrey M Gimble Journal: Vet Surg Date: 2008-12 Impact factor: 1.495